外阴恶性肿瘤中P21、ILK及HPV6/11、HPV16/18的检测及意义  被引量:2

Detection and significance of P21, ILK and HPV 6/11, HPV 16/18 in vulvar malignant tumor

在线阅读下载全文

作  者:李胜水[1] 葛风芹[2] 刘春在 许华[1] 李双标[1] 张凤梅[1] 刘岩[1] 

机构地区:[1]河北省沧州中西医结合医院病理科,河北沧州061001 [2]河北省沧州市传染病医院,河北沧州061001 [3]河北省南大港医院,河北沧州061103

出  处:《中国医药导报》2010年第4期13-15,共3页China Medical Herald

摘  要:目的:探讨P21、ILK及HPV 6/11、HPV 16/18与外阴恶性肿瘤的关系。方法:P21、ILK用免疫组化SP法检测,HPV 6/11、HPV 16/18用原位杂交法(ISH)检测。结果:外阴恶性肿瘤组、外阴上皮内瘤变(VIN)组、正常组中,P21、ILK的阳性表达率分别为40.00%(12/30)、52.38%(11/21)、0(0/10)和63.33%(19/30)、47.62%(10/21)、0(0/10);外阴病变各组P21、ILK的阳性表达率均显著高于正常组(P<0.05)。外阴恶性肿瘤组、VIN组中HPV 6/11、HPV 16/18的阳性表达率分别为60.00%(18/30)、42.86%(9/21)和33.33%(10/30)、28.57%(6/21),正常对照组未检测出;HPV 6/11在外阴恶性肿瘤组、VIN组中的阳性表达率均显著高于正常组(P<0.05);HPV 16/18在外阴恶性肿瘤组中的阳性表达率显著高于正常组(P<0.05)。结论:P21、ILK及HPV感染在外阴恶性肿瘤的发生及发展中可能起一定的作用。Objective: To investigate the relationships between P21, ILK and HPV 6/11, HPV 16/18 and vulvar malignant tumor. Methods: P21 and ILK were stained immunohistochemieally, and HPV 6/11 as well as HPV 16/18 were detected by using in site hybridization method. Results: The expression rates of P21 and ILK in vulvar malignant tumor group, VIN group and normal group were 40.00% (12/30), 52.38% (11/21), 0(0/10) and 63.33% (19/30), 47.62% (10/21), 0 (0/10) respec tively, with significant difference among the vulvar lesions and normal skin epithelium (P〈0.05). The positive rates of HPV 6/11, HPV 16/18 in vulvar malignant tumor group and VIN group were 60.00% (18/30), 42.86% (9/21) and 33.33% (10/30), 28.57% (6/21) respectively, and there was no HPV 6/11 or HPV 16/18 in normal skin epithelium. The positive rate of HPV 6/11 in vulvar lesions was significantly higher than that of the normal skin epithelium (P〈0.05). Meanwhile, the positive rate of HPV 16/18 in vulvar malignant tumor was significantly higher than that of the normal skin epithelium (P〈0.05). Conclusion: Over expression of P21, ILK and HPV 6/11, HPV 16/18 may play a role in the development and progress of vular malignant tumor.

关 键 词:外阴恶性肿瘤 人乳头瘤病毒 P21 ILK 

分 类 号:R737.35[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象